<node id="72842">
  <nid>72842</nid>
  <type>event</type>
  <uid>
    <user id="27195"><![CDATA[27195]]></user>
  </uid>
  <created>1321450906</created>
  <changed>1475891801</changed>
  <title><![CDATA[Bioengineering Seminar Series]]></title>
  <body><![CDATA[<p><em><strong>"Design of Peptide-and Aptamer-Amphiphiles for Receptor-Targeted Therapeutics"&nbsp;</strong></em><br /><br /><strong>Efrosini Kokkoli, PhD - University of Minnesota</strong><br /><br />Drug delivery systems that include site-specific surface ligands could further enhance selective targeting. In this talk I will discuss the design and evaluation of two different ligands. The first one is a fibronectin mimetic peptide-amphiphile, PR_b, that specifically targets the alpha(5)beta(1) integrin which is over-expressed in a variety of cancer cells and on tumor vasculature, and plays an important role in angiogenesis and metastasis. PR_b functionalized nanoparticles have been evaluated in vitro and in vivo and have shown enhanced binding, intracellular uptake, and delivery of their encapsulated load compared to non-targeted and GRGDSP-functionalized particles targeted to different cancers, as well as the capability to deliver a wide variety of therapeutic cargoes. The second example is our recent effort to design a ligand for fractalkine. Fractalkine is a chemokine that acts as an adhesion molecule for leukocytes and more important is only expressed at sites of inflammation, such as cancer. We have recently identified an aptamer, FKN-S2, that binds fractalkine with high affinity and specificity. Our results demonstrate the effect of the hydrophobic tail of the aptamer-amphiphile on its self-assembly and binding characteristics.<br /><br />Host: &nbsp;<a href="mailto:valeria.milam@mse.gatech.edu">Valeria Milam, PhD</a></p><p>The Bioengineering Seminar Series is a joint seminar series between IBB and the BME department. Seminars are held on Tuesdays or Thursdays between 11am-12pm in IBB room 1128 unless otherwise indicated.</p>]]></body>
  <field_summary_sentence>
    <item>
      <value><![CDATA["Design of Peptide- and Aptamer-Amphiphiles for Receptor-Targeted Therapeutics" - Efrosini Kokkoli, PhD - University of Minnesota]]></value>
    </item>
  </field_summary_sentence>
  <field_summary>
    <item>
      <value><![CDATA[<p>Bioengineering Seminar Series - "Design of Peptide- and Aptamer-Amphiphiles for Receptor-Targeted Therapeutics" -&nbsp;Efrosini Kokkoli, PhD - University of Minnesota</p>]]></value>
    </item>
  </field_summary>
  <field_time>
    <item>
      <value><![CDATA[2012-04-26T12:00:00-04:00]]></value>
      <value2><![CDATA[2012-04-26T13:00:00-04:00]]></value2>
      <rrule><![CDATA[]]></rrule>
      <timezone><![CDATA[America/New_York]]></timezone>
    </item>
  </field_time>
  <field_fee>
    <item>
      <value><![CDATA[]]></value>
    </item>
  </field_fee>
  <field_extras>
      </field_extras>
  <field_audience>
      </field_audience>
  <field_media>
          <item>
        <nid>
          <node id="124031">
            <nid>124031</nid>
            <type>image</type>
            <title><![CDATA[Efrosini Kokkoli, PhD - University of Minnesota]]></title>
            <body><![CDATA[]]></body>
                          <field_image>
                <item>
                  <fid>194456</fid>
                  <filename><![CDATA[kokkoli-800x600.jpg]]></filename>
                  <filepath><![CDATA[/sites/default/files/images/kokkoli-800x600_0.jpg]]></filepath>
                  <file_full_path><![CDATA[http://hg.gatech.edu//sites/default/files/images/kokkoli-800x600_0.jpg]]></file_full_path>
                  <filemime>image/jpeg</filemime>
                  <image_740><![CDATA[]]></image_740>
                  <image_alt><![CDATA[Efrosini Kokkoli, PhD - University of Minnesota]]></image_alt>
                </item>
              </field_image>
            
                      </node>
        </nid>
      </item>
      </field_media>
  <field_contact>
    <item>
      <value><![CDATA[<p><a href="mailto:valeria.milam@mse.gatech.edu">Valeria Milam, PhD</a></p>]]></value>
    </item>
  </field_contact>
  <field_location>
    <item>
      <value><![CDATA[]]></value>
    </item>
  </field_location>
  <field_sidebar>
    <item>
      <value><![CDATA[]]></value>
    </item>
  </field_sidebar>
  <field_phone>
    <item>
      <value><![CDATA[(404) 894-6228]]></value>
    </item>
  </field_phone>
  <field_url>
    <item>
      <url><![CDATA[http://www.ibb.gatech.edu]]></url>
      <title><![CDATA[]]></title>
            <attributes><![CDATA[]]></attributes>
    </item>
  </field_url>
  <field_email>
    <item>
      <email><![CDATA[valeria.milam@mse.gatech.edu]]></email>
    </item>
  </field_email>
  <field_boilerplate>
    <item>
      <nid><![CDATA[]]></nid>
    </item>
  </field_boilerplate>
  <links_related>
          <item>
        <url>http://www.cems.umn.edu/about/people/faculty.php?id=20282</url>
        <link_title><![CDATA[Kokkoli profile]]></link_title>
      </item>
          <item>
        <url>http://www.ibb.gatech.edu/bioe-seminars</url>
        <link_title><![CDATA[BIOE Seminar Series schedule]]></link_title>
      </item>
      </links_related>
  <files>
      </files>
  <og_groups>
          <item>1292</item>
      </og_groups>
  <og_groups_both>
          <item><![CDATA[Parker H. Petit Institute for Bioengineering and Bioscience (IBB)]]></item>
      </og_groups_both>
  <field_categories>
          <item>
        <tid>1795</tid>
        <value><![CDATA[Seminar/Lecture/Colloquium]]></value>
      </item>
      </field_categories>
  <field_keywords>
          <item>
        <tid>30331</tid>
        <value><![CDATA[and delivery of their encapsulated load compared to non-targeted and GRGDSP-functionalized particles targeted to different cancers]]></value>
      </item>
          <item>
        <tid>30311</tid>
        <value><![CDATA[and plays an important role in angiogenesis and metastasis. PR_b functionalized nanoparticles have been evaluated in vitro and in vivo and have shown enhanced binding]]></value>
      </item>
          <item>
        <tid>30341</tid>
        <value><![CDATA[as well as the capability to deliver a wide variety of therapeutic cargoes. The second example is our recent effort to design a ligand for fractalkine. Fractalkine is a chemokine that acts as an adhesion molecule for leukocytes and more important is only]]></value>
      </item>
          <item>
        <tid>11877</tid>
        <value><![CDATA[BioE Seminar]]></value>
      </item>
          <item>
        <tid>30281</tid>
        <value><![CDATA[Drug delivery systems that include site-specific surface ligands could further enhance selective targeting. In this talk I will discuss the design and evaluation of two different ligands. The first one is a fibronectin mimetic peptide-amphiphile]]></value>
      </item>
          <item>
        <tid>15097</tid>
        <value><![CDATA[Efrosini Kokkoli]]></value>
      </item>
          <item>
        <tid>248</tid>
        <value><![CDATA[IBB]]></value>
      </item>
          <item>
        <tid>30321</tid>
        <value><![CDATA[intracellular uptake]]></value>
      </item>
          <item>
        <tid>30291</tid>
        <value><![CDATA[PR_b]]></value>
      </item>
          <item>
        <tid>30301</tid>
        <value><![CDATA[that specifically targets the alpha(5)beta(1) integrin which is over-expressed in a variety of cancer cells and on tumor vasculature]]></value>
      </item>
      </field_keywords>
  <field_userdata><![CDATA[]]></field_userdata>
</node>
